Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?
Conclusion
Early treatment with newer combinations of DAAs for recurrent HCV after the first 3 months after LT is recommended to achieve high rates of SVR and adequate safety profile.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research
More News: Egypt Health | Gastroenterology | Hepatitis | Hepatitis C | History of Medicine | Liver | Liver Transplant | Norvir | Study | Transplants | Urology & Nephrology | Virology